152 related articles for article (PubMed ID: 6687659)
1. Nature of calcemic effect of 1,25-dihydroxyvitamin D3 in experimental hypoparathyroidism.
Hefti E; Trechsel U; Fleisch H; Bonjour JP
Am J Physiol; 1983 Apr; 244(4):E313-6. PubMed ID: 6687659
[TBL] [Abstract][Full Text] [Related]
2. Effect of thyroparathyroidectomy of calcium metabolism in rats: role of 1,25-dihydroxyvitamin D3.
Rizzoli R; Fleisch H; Bonjour JP
Am J Physiol; 1977 Sep; 233(3):E160-4. PubMed ID: 910902
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,25-dihydroxyvitamin D3 on the renal handling of Pi in thyroparathyroidectomized rats.
Bonjour JP; Preston C; Fleisch H
J Clin Invest; 1977 Dec; 60(6):1419-28. PubMed ID: 915006
[TBL] [Abstract][Full Text] [Related]
4. Extrarenal handling of phosphate: effect of thyroparathyroidectomy, 1,25-dihydroxycholecalciferol, and dietary calcium.
Troehler U; Bonjour JP; Fleisch H
Am J Physiol; 1985 Dec; 249(6 Pt 2):F912-8. PubMed ID: 3840955
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of parathyroid hormone on the renal 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 production of young and adult rats.
Armbrecht HJ; Wongsurawat N; Zenser TV; Davis BB
Endocrinology; 1982 Oct; 111(4):1339-44. PubMed ID: 6981502
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydrochlorothiazide on 1,25-dihydroxyvitamin D3-induced changes in calcium metabolism in experimental hypoparathyroidism in rats.
Rizzoli R; Hugi K; Fleisch H; Bonjour JP
Clin Sci (Lond); 1981 Jan; 60(1):101-7. PubMed ID: 6894567
[TBL] [Abstract][Full Text] [Related]
7. Renal handling of calcium: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3.
Hugi K; Bonjour JP; Fleisch H
Am J Physiol; 1979 Apr; 236(4):F349-56. PubMed ID: 434208
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 metabolite injections to thyroparathyroidectomized pregnant rats: effects on calcium-binding proteins of maternal duodenum and of fetoplacental unit.
Garel JM; Delorme AC; Marche P; Nguyen TM; Garabedian M
Endocrinology; 1981 Jul; 109(1):284-9. PubMed ID: 6263587
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 enhances the effect of refeeding on steady state preproinsulin messenger ribonucleic acid levels in rats.
Ozono K; Seino Y; Yano H; Yamaoka K; Seino Y
Endocrinology; 1990 Apr; 126(4):2041-5. PubMed ID: 2180682
[TBL] [Abstract][Full Text] [Related]
12. 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.
Burnatowska-Hledin MA; Doyle TM; Eadie MJ; Mayor GH
J Lab Clin Med; 1986 Aug; 108(2):96-102. PubMed ID: 3755457
[TBL] [Abstract][Full Text] [Related]
13. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
Haq M; Kremer R; Goltzman D; Rabbani SA
J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
[TBL] [Abstract][Full Text] [Related]
14. Modulation of renal production of 24,25- and 1,25-dihydroxyvitamin D3 in young and adult rats by dietary calcium, phosphorus, and 1,25-dihydroxyvitamin D3.
Armbrecht HJ; Zenser TV; Davis BB
Endocrinology; 1982 Jun; 110(6):1983-8. PubMed ID: 6978809
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
Magliola L; Anast CS; Forte LR
Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
[TBL] [Abstract][Full Text] [Related]
16. 1,25-Dihydroxyvitamin D3 injections into rat fetuses : effects on fetal plasma calcium, plasma phosphate and mineral content.
Chalon S; Garel JM
Reprod Nutr Dev (1980); 1983; 23(3):567-73. PubMed ID: 6688475
[TBL] [Abstract][Full Text] [Related]
17. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
[TBL] [Abstract][Full Text] [Related]
18. Effects of oxidation of human parathyroid hormone on its biological activity in continuously infused, thyroparathyroidectomized rats.
Horiuchi N
J Bone Miner Res; 1988 Jun; 3(3):353-8. PubMed ID: 3213628
[TBL] [Abstract][Full Text] [Related]
19. 24,25(OH)2D3 enhances the calcemic effect of 1,25(OH)2D3 in PTX rats.
Wald H; Traves J; Popovtzer MM
Proc Soc Exp Biol Med; 1987 Jan; 184(1):47-9. PubMed ID: 3491995
[TBL] [Abstract][Full Text] [Related]
20. Suppression of PTH and decreased action on bone are partially responsible for the low calcemic activity of 22-oxacalcitriol relative to 1,25-(OH)2D3.
Finch JL; Brown AJ; Mori T; Nishii Y; Slatopolsky E
J Bone Miner Res; 1992 Jul; 7(7):835-9. PubMed ID: 1642151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
